Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Vávrová, , Ludmila,
DOB: 08-AUG-1940 (Age: 85)
Gender: female
Address:
Šárovo Kolo 116
29471 Bakov nad Jizerou (Czechia)
ID: 1992-540676-1 (ECI)
Report
Date: 04-DEC-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Psychiatrická nemocnice Kosmonosy
293 06 Kosmonosy (Czechia)
Specimen
Collected: 04-DEC-2024

Chemistry

Test 04-DEC-2024 Reference Range Unit
Glucose [Mass/volume] in Blood 64.9 L 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 3.4 H 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 142.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.5 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 110.2 H 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.2 L 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.1 L 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.4 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 3.0 2.2 - 3.7 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 87.8 40 - 130 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 45.4 7 - 55 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.5 10 - 40 U/L
Cholesterol [Mass/volume] in Serum or Plasma 199.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 110.2 10 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 140.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.0 L 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows impaired renal function (elevated creatinine), mild hypoglycemia, low total protein, metabolic acidosis (low CO₂), hyperchloremia, and dyslipidemia (high LDL, low HDL). These findings suggest possible chronic kidney disease with associated metabolic disturbances and increased cardiovascular risk. Clinical correlation and further evaluation are recommended.